Lung Cancer

Sponsor: Easton Cooperative Group (ECOG)

Study: A021502

Phase III

Reducing Surgical Complications in Newly Diagnosed Lung Cancer Patients Who Smoke Cigarettes

Eligibility Criteria:

  • Eligible patients will have either confirmed or suspected new diagnosis of lung cancer and have sought a surgical consult relating to this diagnosis
  • Surgery scheduled no sooner than 10 days after, and no more than 12 weeks after randomization
  • Have smoked daily or nearly every day in the previous 6 months up to the date of surgical consult AND have smoked at least one puff in the previous 7 days
  • Motivated to stop smoking
  • Cannot be currently using (past 30 days) any pharmacologic treatment using any nicotine delivery system (i.e., e-cigarettes and vape products)
  • No allergies to or not currently using varenicline
  • No unstable angina, myocardial infarction, or coronary angioplasty within the past 3 months or an untreated cardiac dysrhythmia
  • No history of seizures
  • No unstable neurologic, hepatic, renal, cardiovascular, lymphatic, or metabolic disease

To learn more about available clinical research trials contact:

Deborah Brunetti, RN, CRC
Hunterdon Regional Cancer Center – Research Department
2100 Wescott Drive
Flemington, NJ 08822
908-237-2330 option #3